Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion, |
RCV000210929 | SCV002012079 | pathogenic | Multiple congenital anomalies-hypotonia-seizures syndrome 3 | 2021-10-02 | criteria provided, single submitter | clinical testing | Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.0000159, PM2). The variant was observed in trans with a pathogenic variant (NM_015937.5:c.1342C>T) as compound heterozygous (3billion dataset, PM3). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Revvity Omics, |
RCV001782700 | SCV002018805 | pathogenic | not provided | 2019-11-21 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000210929 | SCV000267596 | pathogenic | Multiple congenital anomalies-hypotonia-seizures syndrome 3 | 2016-04-25 | no assertion criteria provided | literature only |